Brigit Biofarmaka Teknologi Tbk. vs Satria Mega Kencana Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume), while Satria Mega Kencana Tbk. trades at Rp630 (market cap 600B, 774.5K 24h volume). The key difference: Satria Mega Kencana Tbk. is far larger — about 3.5× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Satria Mega Kencana Tbk. is more actively traded (774.5K versus 592.2K). Which is the better fit depends on your goals.
| OBAT | SOTS | |
|---|---|---|
Market Cap | 172.82B | 600B |
Volume | 592.2K | 774.5K |
Lot | 5.92K | 7.75K |
Turnover | 147.05M | 489.99M |
Average Price | 248.31 | 632.65 |
Value | 147.05M | 489.99M |
Indicative Equilibrium Price | 254 | 630 |
Indicative Equilibrium Volume | 10 | 20 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Satria Mega Kencana Tbk (the Company) was established based on Notarial Deed No. 62 of Ilmiawan Dekrit Supatmo, S.H., dated June 16, 2004, notary in Jakarta.
Read more on SOTS →